Predictive Oncology CFO Bob Myers to resign Sept 30; Josh Blacher named Interim CFO

Axe Compute Inc.

CFO Bob Myers notified resignation effective September 30, 2023, after nearly 12 years of service.
Company entered consulting agreement with Danforth Advisors for interim CFO services.
Josh Blacher of Danforth appointed Interim CFO; will serve as principal financial and accounting officer post-Transition Date.
Blacher is Managing Partner at Columbus Circle Capital and has prior CFO roles at Galmed, Therapix, and Inmed Pharmaceuticals.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Josh Blacher

Interim Chief Financial Officer

AGPU · Axe Compute Inc.

Effective: 2023-09-30
Filed: August 17, 2023, 7:59 PM ET

Josh Blacher of Danforth, an experienced biotech executive who specializes in strategic finance and corporate development, has been named as the Company’s Interim Chief Financial Officer.

Departed

Bob Myers

Chief Financial Officer, Corporate Secretary and Compliance Officer

AGPU · Axe Compute Inc.

Effective: 2023-09-30
Successor: Josh Blacher
Filed: August 17, 2023, 7:59 PM ET

Bob Myers, the Chief Financial Officer, Corporate Secretary and Compliance Officer of Predictive Oncology Inc. (the "Company"), notified the Company of his intent to resign from the Company effective September 30, 2023 (the "Transition Date").

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Josh Blacher was named as Interim Chief Financial Officer at Axe Compute Inc..

Action: named
Role: Interim Chief Financial Officer

Exact text from the filing

Josh Blacher of Danforth, an experienced biotech executive who specializes in strategic finance and corporate development, has been named as the Company’s Interim Chief Financial Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Bob Myers resigned as Chief Financial Officer, Corporate Secretary and Compliance Officer at Axe Compute Inc..

Action: resigned
Role: Chief Financial Officer, Corporate Secretary and Compliance Officer

Exact text from the filing

Bob Myers, the Chief Financial Officer, Corporate Secretary and Compliance Officer of Predictive Oncology Inc. (the "Company"), notified the Company of his intent to resign from the Company effective September 30, 2023 (the "Transition Date").

View on SEC.gov

Axe Compute Inc. filing history →

Source: SEC EDGAR

accession 0001171843-23-005359

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.